Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Blis MD vs Piper

By GLP-1 ScorecardUpdated

Blis MD
Site position #85

Lower grade

Piper
Site position #31

Higher grade

Score comparison

Piper has the higher recorded score — 81.9/100 to 72.7/100.

Piper grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Mid-value both-molecule pricing ($135/$199), nationwide, though not verified.

We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.

Factor by factor

These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.

Cost valueBlis MD +2
88
86
Dose & formulationPiper +8
72
80
Clinical oversightPiper +5
74
79
Labs & monitoringPiper +16
62
78
FulfillmentPiper +21
65
86
Contract termsPiper +27
55
82
Blis MD · top barPiper · bottom bar

The numbers

Swipe or scroll to compare both providers.

MetricBlis MDPiper
WeighScore72.7/10081.9/100
GradeCB−
Site position#85#31
Semaglutide$139/mo$135/mo
Tirzepatide$199/mo$199/mo
CoverageCoverage not publishedAll 50 states
Brand-name accessNot confirmedNot confirmed
Oral / sublingualNot confirmedNot confirmed
Blis MD

Site position #85 · C

Strengths

  • Transparent flat monthly pricing published upfront (139 dollars semaglutide, 199 dollars tirzepatide)
  • Free initial virtual consultation with a licensed provider
  • Both semaglutide and tirzepatide offered with ongoing provider check-ins

What to consider

  • Compounding pharmacy is not named publicly
  • States served are not listed on the site
  • Thin public trust signals (no LegitScript seal or named medical director found)
Piper

Site position #31 · B−

Strengths

  • $135 sema / $199 tirz
  • All 50 states
  • Both molecules

What to consider

  • Independent LegitScript certification has not been verified for this review
  • Injection-only
  • Monitoring detail limited

Featured provider

CoreAge Rx

CoreAge Rx scores 89.5/100 (B+). Advertises pricing across doses with no membership fee, but starting-price displays and FAQ payment/refund promises need to be reconciled with the selected plan and refund policy.

Commercial relationships affect this placement. The score comparison above is separate.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard